Sarah Afif
Overview
Explore the profile of Sarah Afif including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
0
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Araji G, Keesari P, Chowdhry V, Valsechi-Diaz J, Afif S, Diab W, et al.
World J Nephrol
. 2024 Dec;
13(4):100268.
PMID: 39723360
Vitamin B12 deficiency is a significant concern among patients with end-stage renal disease undergoing dialysis. However, there hasn't been extensive research conducted on this particular patient group. The reported incidence...
2.
Balduyck M, Afif S, Onraed B, Jourdain M, Nseir S, Pigny P, et al.
Biochimie
. 2024 Nov;
230:114-120.
PMID: 39557332
Alpha-1 antitrypsin (A1AT) is the major circulating serine protease inhibitor. Hypersialylated glycoforms (HSG) are produced to boost A1AT anti-inflammatory and anti-protease properties. Their occurrence and prognostic impact outside severe COVID-19...
3.
Khan S, Yetiskul E, Khattar G, Ghada A, Afif S, Khan M, et al.
Eur J Case Rep Intern Med
. 2024 Jul;
11(7):004619.
PMID: 38984175
Introduction: Renal squamous cell carcinoma (SCC) is a neoplasm with an extremely rare occurrence compared to other renal malignancies. The classic presentation includes a palpable mass and flank pain; however,...
4.
Khan S, Araji G, Yetiskul E, Keesari P, Haddadin F, Khamis Z, et al.
World J Clin Oncol
. 2024 Jul;
15(6):730-744.
PMID: 38946836
The advancement of renal replacement therapy has significantly enhanced the survival rates of patients with end-stage renal disease (ESRD) over time. However, this prolonged survival has also been associated with...